Data from Phase I Dose-Escalation Study of Onartuzumab as a Single Agent and in Combination with Bevacizumab in Patients with Advanced Solid MalignanciesRavi Salgia, Premal Patel,John Bothos, Wei Yu,Steve Eppler,Priti Hegde,Shuang Bai,Surinder Kaur,Ihsan Nijem,Daniel V.T. Catenacci,Amy Peterson,Mark J. Ratain,Blase Polite, Janice M. Mehnert,Rebecca A. Mosscrossref（2023）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
